These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11311294)

  • 1. A neuropathological study of the disturbance of the nigro-amygdaloid connections in brains from patients with dementia with Lewy bodies.
    Iseki E; Kato M; Marui W; Uéda K; Kosaka K
    J Neurol Sci; 2001 Apr; 185(2):129-34. PubMed ID: 11311294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
    Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
    Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disturbance of the nigro-amygdaloid connections in dementia with Lewy bodies.
    Jellinger KA
    J Neurol Sci; 2002 Jan; 193(2):157-8. PubMed ID: 11790397
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining.
    Gómez-Tortosa E; Newell K; Irizarry MC; Sanders JL; Hyman BT
    Acta Neuropathol; 2000 Apr; 99(4):352-7. PubMed ID: 10787032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies.
    Rozemuller AJ; Eikelenboom P; Theeuwes JW; Jansen Steur EN; de Vos RA
    Acta Neuropathol; 2000 Dec; 100(6):701-8. PubMed ID: 11078223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies.
    Yamamoto R; Iseki E; Murayama N; Minegishi M; Marui W; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
    J Neurol Sci; 2006 Jul; 246(1-2):95-101. PubMed ID: 16624323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study.
    Wakisaka Y; Furuta A; Tanizaki Y; Kiyohara Y; Iida M; Iwaki T
    Acta Neuropathol; 2003 Oct; 106(4):374-82. PubMed ID: 12904992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
    Greffard S; Verny M; Bonnet AM; Seilhean D; Hauw JJ; Duyckaerts C
    Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell death mechanisms in Parkinson's disease.
    Jellinger KA
    J Neural Transm (Vienna); 2000; 107(1):1-29. PubMed ID: 10809400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of oxidative stress in the neocortex in incidental Lewy body disease.
    Dalfó E; Portero-Otín M; Ayala V; Martínez A; Pamplona R; Ferrer I
    J Neuropathol Exp Neurol; 2005 Sep; 64(9):816-30. PubMed ID: 16141792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degeneration of tyrosine hydroxylase-immunoreactive neurons in the cerebral cortex and hippocampus of patients with dementia with Lewy bodies.
    Marui W; Iseki E; Kato M; Kosaka K
    Neurosci Lett; 2003 Apr; 340(3):185-8. PubMed ID: 12672537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies.
    Barrachina M; Castaño E; Dalfó E; Maes T; Buesa C; Ferrer I
    Neurobiol Dis; 2006 May; 22(2):265-73. PubMed ID: 16380264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers.
    Beach TG; Walker DG; Sue LI; Newell A; Adler CC; Joyce JN
    J Neuropathol Exp Neurol; 2004 Apr; 63(4):329-37. PubMed ID: 15099023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuritic alterations and neural system dysfunction in Alzheimer's disease and dementia with Lewy bodies.
    Klucken J; McLean PJ; Gomez-Tortosa E; Ingelsson M; Hyman BT
    Neurochem Res; 2003 Nov; 28(11):1683-91. PubMed ID: 14584822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using alpha-synuclein-immunohistochemistry.
    Iseki E; Marui W; Akiyama H; Uéda K; Kosaka K
    Neurosci Lett; 2000 May; 286(1):69-73. PubMed ID: 10822155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.